JPM23: Moderna reaped $18.4B in COVID vaccine sales last year, projects at least $5B in 2023

Throughout 2022, headlines regularly documented the decline in COVID-19 vaccine demand, prompting market watchers to wonder how the leading manufacturers would fare on the sales front. On Monday, Moderna provided new clues about the state of the COVID shot market.